InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Browse the complete record of transactions filed by Lee Philina. Officer active across 1 company, notably Blueprint Medicines Corp. In total, 10 disclosures have been logged. Split: 0 buy · 3 sells. Total volume traded: €626k. History available since 1 March 2023. The latest transaction was filed on 5 March 2025 (Cession). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
10 条申报中的 10 条
Lee Philina is an insider linked to Blueprint Medicines Corp, where the listed role is Chief Commercial Officer. Across 10 filings in total, the 10 sampled filings cover the period from 2023-03-03 to 2025-07-21, with EUR 0 in buys and EUR 625845 in sells, and the modal transaction nature is Attribution.